Irinotecan in the treatment of small cell lung cancer: a review of patient safety considerations

Expert Opinion on Drug Safety
Masaaki Kawahara

Abstract

A water soluble derivative of camptothecin, irinotecan (CPT-11) is effective against small-cell lung cancer (SCLC), as well as non-SCLC and gastrointestinal cancers. This extended review of recently concluded and ongoing studies focuses on irinotecan in the treatment of limited (LD) and extensive (ED) SCLC specifically considering the safety of patients. Irinotecan-induced diarrhoea is pervasive, and can be severe and life-threatening especially in combination with neutropenia. It can have a significant impact on patient quality of life, negatively influencing compliance with therapy and dose-intensity. For LD SCLC, irinotecan can be administered with radiotherapy concurrently or sequentially. In a Phase III study for ED SCLC comparing etoposide and cisplatin (EP) and irinotecan and cisplatin (IP) regimens, severe myelosuppression was more frequent in the EP arm than in the IP arm, and conversely severe or life-threatening diarrhoea was more frequent in the IP arm than in the EP arm. IP resulted in significantly higher response rates and overall survival in Japan, and confirmatory Phase III studies are ongoing. Irinotecan should not be administered to patients with any degree of ongoing diarrhoea above their baseline. Irinoteca...Continue Reading

References

Jun 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P Warde, D Payne
Aug 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N MasudaM Takada
Dec 3, 1992·The New England Journal of Medicine·J P PignonB Lebeau
Mar 16, 1994·Journal of the National Cancer Institute·D AbigergesD Gandia
Dec 13, 1996·Annals of the New York Academy of Sciences·J P ArmandO Rixe
Feb 1, 1997·Japanese Journal of Cancer Research : Gann·K TamuraM Yamakido
Jun 1, 1997·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·N Murray
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S KudohM Fukuoka
Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N MasudaM Fukuoka
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J von PawelR Gralla
Aug 17, 1999·Cancer Treatment Reviews·C HuismanE F Smit
Aug 17, 1999·International Journal of Cancer. Journal International Du Cancer·P PisaniJ Ferlay
Jan 11, 2002·The New England Journal of Medicine·Kazumasa NodaUNKNOWN Japan Clinical Oncology Group
Jul 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Diederik F S KehrerAlex Sparreboom
Aug 22, 2002·Journal of the National Cancer Institute·Ron H J MathijssenAlex Sparreboom
Sep 18, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Nobuyuki NakaKiyoyuki Furuse
Feb 7, 2003·Current Medicinal Chemistry·M K Ma, H L McLeod
Apr 19, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I SekineUNKNOWN Japan Clinical Oncology Group (JCOG) Lung Cancer Study Group
May 6, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Alex SparreboomWilliam D Figg
Jun 5, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Takashi HiroseMitsuru Adachi
Oct 21, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Joachim von Pawel
Mar 10, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard L McLeod, James W Watters
Mar 12, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Masahiro AndoShoji Kudoh
Mar 16, 2004·Pharmacogenomics·Howard L McLeod
Jun 16, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Roger StuppSerge Leyvraz
Jun 26, 2004·Oncology·Sofia AgelakiUNKNOWN Lung Cancer Subgroup, Hellenic Oncology Research Group
Jun 29, 2004·International Journal of Clinical Oncology·Kan YonemoriKoichiro Kudo
Oct 8, 2004·Pharmacogenomics·Sharon Marsh, Howard L McLeod
Nov 24, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Martin WolfThomas Fink
Dec 23, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Glenn Dranoff
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ji-Youn HanJin Soo Lee
Jun 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Koert P de JongAnke van den Berg
Jul 19, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·S KudohY Ariyoshi
Sep 24, 2005·Clinical Lung Cancer·Wolfgang SchuetteThomas Blankenburg

❮ Previous
Next ❯

Citations

Dec 30, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jamie HornMarkos Leggas
Feb 9, 2008·Pharmacology·Howard R Mellor, Richard Callaghan
Mar 26, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Zhe-Yi HuYuan-Sheng Zhao
May 19, 2011·The Journal of Pharmacy and Pharmacology·ChunLei LiPing Wang
Nov 1, 2015·Basic & Clinical Pharmacology & Toxicology·Takaaki KodawaraToshiaki Nakamura
Dec 23, 2006·Clinical Pharmacology and Therapeutics·F A de JongA Sparreboom

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Japanese Journal of Clinical Oncology
Yoshihiro Moriya
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Stuart J WongYi Li
© 2021 Meta ULC. All rights reserved